Atlas Trials

BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALL

Clinical trial NCT07008885 · RECRUITING

Trial details

NCT number
NCT07008885
Sponsor
Chinese PLA General Hospital
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Lymphocytic Leukemia
Start date
2025-06-20
Primary completion
2026-05-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.